Multiple Sclerosis

Author: Jürg Kesselring; W. Ian McDonald; Jane Smith  

Publisher: Cambridge University Press‎

Publication year: 0000

E-ISBN: 9781139243605

Subject: R744.5 demyelinating diseases

Keyword: 神经病学与精神病学

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Multiple Sclerosis

Description

This concise, abundantly illustrated text provides a complete overview of multiple sclerosis for the internist, general neurologist and therapist. Including recent research findings in genetics, immunology and pathophysiology, the authors provide reliable and up-to-date guidance on the epidemiology, diagnosis, prognosis and treatment of MS. Of particular interest to neuroscientists and neurologists will be the reviews of experimental models of MS, pathology of the demyelinated plaque, HLA associations and the role of immune mechanisms. Environmental and geographical factors in the etiology of MS are examined, including the possible role of infectious agents. The clinical sections of the book include discussion of neurological, sexual, psychological and cognitive disturbances. Diagnostic criteria are reviewed, and rehabilitation measures are given special attention.

Chapter

Shadow plaques

Concentric plaques

Destructive plaques

Plaques with destruction of astrocytes

INFLAMMATION

PATHOLOGY OF THE NERVOUS SYSTEM OUTSIDE THE PLAQUES

DISTRIBUTION OF PLAQUES IN THE NERVOUS SYSTEM

DEVELOPMENT OF PLAQUES

Myelin

Oligodendrocytes

Astroglia

Axons and nerve cells

Remyelination

EXPERIMENTAL MODELS

Experimental autoimmune encephalomyelitis

Target antigens for autoimmunity in EAE

Passive transfer models

Models of virus-induced demyelination

Theiler's virus encqjhalomyelitis

Canine distemper encephalomyelitis

Coronavirus models

Models of inflammatory demyelination in the peripheral nervous system

Experimental autoimmune neuritis

The value of experimental models for MS research

Acknowledgments

Chapter 3 Genetics and immunology

INTRODUCTION

THE HLA SYSTEM

Relation between the HLA system and MS

FAMILY AND TWIN STUDIES

IMMUNOLOGY OF THE CENTRAL NERVOUS SYSTEM

The blood-brain barrier

Interaction of T-lymphocytes with cells of the central nervous system

The role of immune mechanisms in MS patients

Alterations of immunological parameters in the peripheral blood and cerebrospinal fluid of MS patients

Humoral parameters

Cellular parameters

Immunological aspects of animal models

Autoimmune models

Viral models

Chapter 4 Epidemiology

INTRODUCTION

Incidence rate

Mortality rate

Prevalence rate

GEOGRAPHICAL DISTRIBUTION OF PREVALENCE

GEOGRAPHICALLY WELL-DEFINED REGIONS

MIGRATION

DISTRIBUTION ACCORDING TO ACE, SEX, FAMILY, AND RACE

Chapter 5 Pathogenesis

GENERAL PATHOGENESIS

Genetic factors

Familial cases

Twin studies

HLA associations

Environmental factors

Factors triggering exacerbation

SPECIAL PATHOCENESIS OF PLAQUES

Blood-brain barrier

Clinical evidence

MRI findings

Experimental findings

Pathogenesis of the inflammatory reaction

Pathogenesis of demyelination and tissue destruction

SUMMARY OF PATHOGENESIS

Chapter 6 Pathophysiology of impaired neural transmission

ELECTROPHYSIOLOGY OF NORMAL NERVE FIBERS

PATHOPHYSIOLOCY OF DEMYELINATED NERVE FIBERS

Electrophysiological properties

Influence of temperature and calcium

Possible consequences of increased excitability

OTHER MECHANISMS OF IMPAIRED CONDUCTION

Part II Clinical aspects

Chapter 7 Symptomatology

MOTOR ASPECTS

Pareses

Spasticity and reflexes

SENSORY ASPECTS

COORDINATION

OPHTHALMOLOGICAL DISTURBANCES

Optic neuritis

Disturbances of ocular movements

DISTURBANCES OF BLADDER FUNCTION

SEXUAL DISTURBANCES

PSYCHOLOGICAL DISTURBANCES

Premorbid personality

Cognitive functions

Affective disorders

"Stress" and MS

PAIN AND FATIGUE

PAROXYSMAL PHENOMENA AND INVOLUNTARY MOVEMENTS

Epileptic seizures

Paroxysmal phenomena of extracorticalorigin

Facial myokymia

FREQUENCY OF SYMPTOMS

Chapter 8 Diagnosis

INTRODUCTION

DIAGNOSTIC CRITERIA

Relapse and remission

Clinical evidence of lesions

Paraclinical evidence of a lesion

Separated lesions

Laboratory support

Special cases

NEUROPHYSIOLOGICAL INVESTIGATIONS

Introduction

Evoked brain potentials

The principle of afferent evoked brain potentials

Visual evoked potentials

Somatosensory evoked potentials

Brainstem auditory evoked potentials

Examinations of reflexes

Motor evoked potentials induced by transcranial stimulation of the cortex

Assessment of oculomotor disturbances by oculography

Combined cystomanometric- electromyographic investigation of bladder and sphincter function

MAGNETIC RESONANCE IMAGING

Introduction

Sensitivity

Specificity

Magnetic resonance imaging in optic neuropathies and clinically isolated brainstem and spinal cord syndromes

CEREBROSPINAL FLUID

Cerebrospinal fluid profile in multiple sclerosis (Tourtellotte and Walsh 1984)

Comment

DISCUSSING THE DIAGNOSIS

Chapter 9 Disease course

AGE AT DISEASE ONSET

RELAPSING REMITTING COURSE

Relapse rate

Factors triggering or related to relapses

Remission

PRIMARY AND SECONDARY PROGRESSIVE COURSES

FREQUENCY OF VARIOUS COURSES

Chapter 10 Prognosis

LIFE EXPECTANCY

CAUSES OF DEATH

PROGNOSIS OF PROGRESSION

BENIGN COURSES

MALIGNANT COURSES

PROGNOSTIC INDICATORS

Chapter 11 Differential diagnosis

INTRODUCTION

VASCULITIC SYNDROMES

Systemic lupus erythematosus

Primary Sjogren's syndrome

Behcet's syndrome

Granulomatous angiitis of the nervous system

Panarteritis nodosa

INFLAMMATORY AND GRANULOMATOUSDISEASES

Sarcoidosis

Borrelia encephalitis

Acute disseminated encephalomyelitis

Acquired immunodeficiency syndrome

GENETIC AND METABOLIC DISEASES OF THE CENTRAL NERVOUS SYSTEM

Spinocerebellar degeneration

Leukodystrophies

Subacute combined degeneration

TUMORS AND MALFORMATIONS

CERVICAL SPONDYLOSIS

NONORGANIC DISTURBANCES

Chapter 12 Assessment of performance, ability, and disability

Part III Management and therapy

Chapter 13 Symptomatic treatment and nutrition

INTRODUCTION

PHYSIOTHERAPY

EXERCISE MACHINES

ERGOTHERAPY

SPEECH THERAPY

DRUG TREATMENT

Spasticity

Bladder disturbances

Pain

Tremor

Epileptic seizures

Depression

Nutrition

Chapter 14 Therapy

INTRODUCTION

ASSESSING DISEASE EVOLUTION AND THERAPEUTIC EFFECTS

Clinical scales

"Surrogate" markers

MRI

Evoked potential

Laboratory measures

TREATMENTS DIRECTED AT THE MS DISEASE PROCESS

Treatment of relapses

Treatments aimed at reducing relapse rate and halting progression

Nonselective immunosuppressants

Azathioprine

Methotrexate

Cyclophosphamide

Mitoxantrone

Cladribine

Total lymphoid irradiation

Chemically defined substances

Interferon β

Interferon β-lb

Interferon β-la

Other cytokines

Monoclonal antibodies against T-cell sub-populations and activation markers

Various approaches

Oral tolerance

T-cell vaccination

IMPROVEMENT OF CONDUCTION, ENHANCING REMYELINATION

Appendix: Assessment Scales

NEUROLOGICAL ASSESSMENT KURTZKE FUNCTIONAL SYSTEMS (FS)

NEUROLOGICAL ASSESSMENT KURTZKE EXPANDED DISABILITY STATUS SCALE (EDSS)

INCAPACITY STATUS SCALE (ISS)

ENVIRONMENTAL STATUS SCALE (ESS)

MINIMAL RECORD OF DISABILITY SUMMARY RECORD OF CLINICAL SCORES AND NOTES

References

Index

The users who browse this book also browse


No browse record.